What is the Health Sciences Acquisitions Corporation 2 stock price forecast?

Health Sciences Acquisitions Corporation 2 is currently trading at $3.85. View real-time AI analysis on Alpha Lenz.

What is Health Sciences Acquisitions Corporation 2 insider trading activity?

View the latest insider trading data for Health Sciences Acquisitions Corporation 2 on Alpha Lenz.

What is Health Sciences Acquisitions Corporation 2's P/E ratio?

View Health Sciences Acquisitions Corporation 2's valuation metrics on Alpha Lenz.

Health Sciences Acquisitions Corporation 2

NASDAQ · HSAQ

$3.85-0.12(-3.02%)Pre-market

Ask about Health Sciences Acquisitions Corporation 2's future dividend policy...

Alpha Chat Insight

“Health Sciences Acquisitions Corporation 2's ROE is -2.5%. Explore profitability and growth together.”

Ask for details →

Company Overview

SectorUnknown

IndustryUnknown

Company Statistics

FY 2022

Profile

N/AMarket Cap

$0.00Revenue

0.00Shares Out

0Employees

Margins

N/AGross

N/AEBITDA

N/AOperating

N/APre-Tax

N/ANet

Valuation

N/AP/E

N/AP/B

N/AEV/Sales

N/AEV/EBITDA

N/AP/FCF

Growth (CAGR)

N/ARev 3Yr

N/ARev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-2.38%ROA

-2.52%ROE

-2.84%ROIC

Financial Health

$175.16KCash & Cash Equivalents

$201.77KNet Debt

0.62%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Health Sciences Acquisitions Corporation 2's ROE is -2.5%. Explore profitability and growth together.”

Ask for details →

Frequently Asked Questions

Health Sciences Acquisitions Corporation 2 (ticker: HSAQ) is a company listed on NASDAQ in the Unknown sector (Unknown).

The current price is $3.85 with a P/E ratio of -x and P/B of -x.

ROE is -2.52%.